More News

03 May 2017 bluebird bio Licenses Lentiviral Vector Patent Rights for Development and Commercialization of Cell Therapies
03 May 2017 Pieris Pharmaceuticals and AstraZeneca Collaborate to Develop and Commercialize Anticalin-Based Inhaled Treatments for Respiratory Diseases
02 May 2017 Celyad grants to Novartis a non-exclusive license for its allogeneic TCR-deficient CAR-T cells patents
02 May 2017 NeuroVive in-licenses a Genetic Mitochondrial Disease Clinical Stage Project From Yungjin Pharm
02 May 2017 Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications
28 Apr 2017 Takeda and Harrington Discovery Institute at University Hospitals Announce a Collaboration to Advance the Development of Rare Disease Therapeutics
26 Apr 2017 Servier and Vernalis plc announce achievement of 3 milestones in their oncology drug discovery collaboration
26 Apr 2017 Xenon Expands Ion Channel Neurology Pipeline with Acquisition of New Potassium Channel Modulator for the Treatment of Epilepsy
26 Apr 2017 Akebia and Otsuka Expand Relationship with Collaboration to Develop and Commercialise Vadadustat in Europe, China and Other Territories
26 Apr 2017 Sienna Biopharmaceuticals Announces $40 Million Series B Financing
25 Apr 2017 Domain Therapeutics and Pfizer Inc. enter into collaboration agreement on bioSensAllâ„¢
25 Apr 2017 Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 (erenumab) program in migraine prevention in the US and Canada
25 Apr 2017 Merck Divests Biosimilars Business to Fresenius
20 Apr 2017 Lion Biotechnologies Announces Strategic Alliance with MD Anderson Cancer Center to Conduct Clinical Trials of TILs in Multiple Solid Tumors
19 Apr 2017 Parvus Therapeutics Announces Exclusive Worldwide License and Collaboration Agreement for the Development and Commercialization of Its Lead Nanomedicine to Treat Type 1 Diabetes
18 Apr 2017 Ionis Enters into Collaboration with Ribo to Advance RNA-Targeted Therapeutics in China
18 Apr 2017 HitGen and Pfizer Enter Research Collaboration and License Agreement to Build and Screen Novel DNA-Encoded Libraries
18 Apr 2017 VALNEVA Announces Signing of a New EB66® Commercial License with Bavarian Nordic
18 Apr 2017 Novartis expands development programs for NASH through clinical collaboration with Allergan
17 Apr 2017 CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with StrideBio
14 Apr 2017 Bristol-Myers Squibb Enters into Separate Agreements with Biogen and Roche to License Anti-eTau and Anti-Myostatin Compounds, Respectively
11 Apr 2017 LDC and SOTIO Enter License and Collaboration Agreement for First-in-class Cancer Metabolism Program
11 Apr 2017 Takeda Enters into Strategic Collaboration with NuBiyota for Microbiome Therapeutics
10 Apr 2017 Ferring Announces Exclusive Agreement with Alrise Biosystems for the Development of an Injectable, Controlled-Release Peptide
07 Apr 2017 Biotest AG and Creat enter into Business Combination Agreement

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing